Atara Biotherapeutics Inc Sustainability Reports
Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company that develops therapies for patients with serious diseases, including cancer and autoimmune diseases. Its pipeline focuses on leveraging its Epstein-Barr virus T-cell platform.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300WBXUXZRE03MS38
FIGI: BBG005Q3MR36
12 reports from 2014 to 2025
